Decision Diagnostics Valuation
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Decision Diagnostics from reviewing the firm fundamentals such as Operating Margin of (0.95) %, shares outstanding of 357.87 M, and Current Valuation of 3.06 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Decision Diagnostics' valuation include:
Price Book 2.7161 | Enterprise Value 3.1 M | Enterprise Value Ebitda (1.49) | Price Sales 0.0168 | Enterprise Value Revenue 1.4379 |
Overvalued
Today
Please note that Decision Diagnostics' price fluctuation is very steady at this time. Calculation of the real value of Decision Diagnostics is based on 3 months time horizon. Increasing Decision Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Decision Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Decision Stock. However, Decision Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Decision Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Decision Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Decision Diagnostics helps investors to forecast how Decision stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Decision Diagnostics more accurately as focusing exclusively on Decision Diagnostics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Decision Diagnostics' intrinsic value based on its ongoing forecasts of Decision Diagnostics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Decision Diagnostics' closest peers.
Decision Diagnostics Cash |
|
Decision Valuation Trend
Knowing Decision Diagnostics' actual value is paramount for traders when making sound investment determinations. Using both Decision Diagnostics' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Decision Diagnostics Total Value Analysis
Decision Diagnostics is currently forecasted to have valuation of 3.06 M with market capitalization of 35.79 K, debt of 2.93 M, and cash on hands of 210.85 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Decision Diagnostics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.06 M | 35.79 K | 2.93 M | 210.85 K |
Decision Diagnostics Investor Information
The company recorded a loss per share of 0.02. Decision Diagnostics had not issued any dividends in recent years. The entity had 1.1:1 split on the 28th of December 2011. Based on the key indicators related to Decision Diagnostics' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Decision Diagnostics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Decision Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Decision Diagnostics has an asset utilization ratio of 35.01 percent. This suggests that the Company is making $0.35 for each dollar of assets. An increasing asset utilization means that Decision Diagnostics is more efficient with each dollar of assets it utilizes for everyday operations.Decision Diagnostics Profitability Analysis
The company reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 194.17 K.About Decision Diagnostics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Decision Diagnostics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Decision Diagnostics based exclusively on its fundamental and basic technical indicators. By analyzing Decision Diagnostics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Decision Diagnostics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Decision Diagnostics. We calculate exposure to Decision Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Decision Diagnostics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 448.6 K | 774.8 K | |
| Pretax Profit Margin | (13.49) | (14.17) | |
| Operating Profit Margin | (0.96) | (1.01) | |
| Net Loss | (13.49) | (14.17) | |
| Gross Profit Margin | 0.23 | 0.15 |
Decision Diagnostics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 356.4 M |
Decision Diagnostics Current Valuation Indicators
Decision Diagnostics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Decision Diagnostics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Decision Diagnostics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Decision Diagnostics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Decision Diagnostics' worth.When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.